FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims - CNBC
The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing misleading claims about the pill.
Search Group
Share To
Comments
About Screade
Screade® Inc. version c2ebf08, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments